Collplant Biotechnologies Ltd current report, Q3 FY2018

CollPlant Biotechnologies Ltd. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by CollPlant Holdings Ltd. on July 27, 2018, covering events occurring in July 2018. The registrant is a foreign private issuer based in Ness Ziona, Israel.

Key Financial Metrics

The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, or debt levels. The only specific financial metric disclosed relates to a capital raise:

  • Capital Raised: Approximately $1.25 million (NIS 4,561,250).
  • Shares Issued: 11,125,000 ordinary shares.
  • Transaction Date: July 26, 2018.

Material Changes

The primary material change reported is the execution of a securities purchase agreement with Ami Sagi. The Company issued and sold shares in a private placement conducted as an offshore transaction under Regulation S.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or contingencies beyond the standard disclosure of the private placement transaction.

Investor Verification Checklist

  • Verify the closing status of the private placement with Ami Sagi.
  • Confirm the exact exchange rate used for the NIS to USD conversion on July 26, 2018.
  • Review the full text of the Securities Purchase Agreement for any restrictive covenants or conditions precedent.
  • Check subsequent filings for the impact of this capital raise on the Company's cash position and share count.